HQY

Healthcare

HealthEquity, Inc. · Medical - Healthcare Information Services · $7B

UQS Score — Balanced Preset
56.4
Good

HealthEquity, Inc. scores 56.4/100 using the Balanced preset.

UQS vs Healthcare Sector
HQY
56.4
Sector avg
32.4
Quality
Good
Moat
Neutral
Growth
Neutral
Risk
Neutral
Valuation
Good

What is HealthEquity, Inc.?

HealthEquity is a technology-enabled health savings platform serving consumers and employers across the United States. Incorporated in 2002 and headquartered in Draper, Utah, it sits at the intersection of healthcare benefits and financial technology.

HealthEquity operates cloud-based platforms that help individuals manage health savings accounts, pay medical bills, compare treatment costs, and make investment decisions tied to their healthcare dollars. Employers and health plans use its infrastructure to administer pre-tax benefit programs including flexible spending accounts, health reimbursement arrangements, and commuter benefits. The company also offers an automated online investment advisory tool and a mutual fund investment platform, generating revenue through account administration fees and investment services.

HealthEquity was incorporated in 2002 and is headquartered in Draper, Utah.

  • Health savings accounts (HSAs) with investment options
  • Flexible spending accounts and health reimbursement arrangements
  • Automated online investment advisory via the Advisor tool
  • COBRA continuation services administration
  • Pre-tax commuter benefit program administration

Is HQY a Good Stock to Buy?

UQS Score rates HQY as Good overall, reflecting a balanced profile with identifiable strengths and areas to watch.

The Growth pillar stands out as a relative bright spot, suggesting the company is expanding its footprint in the health benefits administration space at a pace that compares favorably within its sector. The Valuation pillar also registers as Good, meaning the market's current pricing appears reasonable relative to the company's fundamentals rather than stretched.

Quality, Moat, and Risk each land at Neutral, indicating that competitive differentiation and earnings consistency are not yet among the strongest in the healthcare technology space.

See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →

Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.

Does HQY pay dividends?

No — HealthEquity, Inc. does not currently pay a dividend.

HealthEquity does not currently pay a dividend. For a company in a growth-oriented phase of its lifecycle, this is common — capital is typically reinvested into platform development, client acquisition, and expanding its network of health plan and employer partnerships rather than returned to shareholders as income.

When does HQY report earnings?

HealthEquity reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.

The company's Growth pillar rating suggests its revenue trajectory has been moving in a constructive direction relative to sector peers. Platform expansion and growing HSA account balances have been key themes in recent reporting periods.

For the most recent quarter's results and guidance, visit HealthEquity's investor relations page directly.

HQY Price History

+1.4% over 5Y

Monthly close, adjusted for stock splits and dividend reinvestment.

Return Calculator

What if I invested in HealthEquity, Inc.?

$
Today it would be worth
$12,093
That's a +20.9% total return, or +3.9% annualized.

Based on HealthEquity, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.

HQY Long-term Outlook

HealthEquity's Good Growth pillar points to continued expansion potential, driven by secular tailwinds in consumer-directed healthcare and rising HSA adoption across employer benefit plans. The Neutral Risk pillar suggests the path forward carries moderate execution and competitive risk — not alarming, but worth monitoring. The Good Valuation pillar indicates the market has not yet priced in an overly optimistic scenario, which may leave room for the growth story to develop.

Growth drivers

  • Rising adoption of health savings accounts among US employers and employees
  • Cross-selling investment and advisory services to existing account holders
  • Expansion through health plan and benefits administrator partnerships

Key risks

  • Competitive pressure from larger financial institutions entering the HSA market
  • Regulatory changes affecting pre-tax benefit account rules
  • Integration complexity from acquisitions affecting platform consistency

HQY vs Peers

HealthEquity operates in a healthcare technology and benefits administration space that overlaps with several distinct business models.

BTSGHQY scores higher
BrightSpring Health Services, Inc.

BrightSpring focuses on home and community-based health services rather than technology-driven benefits administration, serving a different segment of the healthcare value chain.

TEMHQY scores higher
Tempus AI, Inc.

Tempus AI applies artificial intelligence to clinical data and precision medicine, competing more on the data analytics side of healthcare rather than consumer benefits platforms.

DOCSHQY scores lower
Doximity, Inc.

Doximity operates a professional network and communications platform for physicians, giving it a provider-facing model that contrasts with HealthEquity's consumer and employer focus.

Frequently Asked Questions

What does HealthEquity do?

HealthEquity provides cloud-based platforms that help individuals manage health savings accounts, pay medical bills, and make investment decisions tied to healthcare spending. It also administers flexible spending accounts, health reimbursement arrangements, COBRA services, and commuter benefit programs for employers and health plans across the United States.

Does HQY pay dividends?

No, HealthEquity does not currently pay a dividend. The company reinvests capital into platform growth, technology development, and expanding its network of employer and health plan clients rather than distributing income to shareholders.

When does HQY report earnings?

HealthEquity reports financial results on a quarterly basis, in line with standard US-listed company practice. For exact dates and the most recent results, check the investor relations section of the company's official website.

Is HQY a good stock to buy?

UQS Score rates HQY as Good overall. The Growth and Valuation pillars are the relative strengths, while Quality, Moat, and Risk each sit at Neutral. Whether that profile fits your investment approach depends on your own criteria — the full pillar breakdown is available to UQS Pro members.

Is HQY overvalued?

The UQS Valuation pillar for HQY is rated Good, suggesting the current market price appears reasonable relative to the company's fundamentals rather than elevated. That said, valuation is one of five pillars — viewing it alongside Quality and Growth context gives a more complete picture.

How does HQY compare to its competitors?

HealthEquity's closest peers in the UQS universe include BrightSpring Health Services, Tempus AI, and Doximity. Each operates a distinct healthcare business model — from home-based services to AI-driven clinical data to physician networking — making direct comparisons nuanced. UQS Pro members can view side-by-side pillar scores.

What is HQY's market cap bracket?

HealthEquity is classified as a mid-cap company. This places it in a tier where growth potential is often still meaningful, but the business has achieved enough scale to operate a broad national platform serving employers, health plans, and millions of individual account holders.

Who founded HealthEquity?

HealthEquity was incorporated in 2002. Founding and leadership history is publicly available through the company's official investor relations materials and SEC filings for those seeking detailed background on its origins.

Is HQY a long-term quality indicator?

As a long-term quality indicator, HQY's UQS profile shows a Good overall score with a constructive Growth pillar and reasonable Valuation. The Neutral readings on Quality, Moat, and Risk suggest the company has room to strengthen its competitive position over time. Pro members can track pillar trends as new data becomes available.

What is the main competitive advantage of HealthEquity?

HealthEquity's platform integrates health savings, spending, and investment decisions in one place, creating switching costs for employers and account holders already embedded in its ecosystem. Its network of health plan and benefits administrator partnerships also provides a distribution advantage that is difficult to replicate quickly.

What sector does HQY belong to?

HealthEquity operates in the Healthcare sector, specifically within health benefits administration and financial technology for consumer-directed healthcare. It sits at the crossroads of healthcare services and fintech, which shapes both its growth opportunity and its competitive landscape.

Is HQY a growth stock or value stock?

Based on UQS pillar labels, HQY leans toward the growth side — its Growth pillar is rated Good while Valuation is also Good, meaning it is not priced at deep-value levels but has not reached the elevated pricing typical of pure high-growth names. It occupies a middle ground between the two categories.

Unlock Full HQY Analysis

Sign in to unlock the detailed analysis behind the UQS Score.

  • View the complete five-pillar UQS Score breakdown
  • Access detailed financial metrics and trend data
  • Compare HQY side-by-side with sector peers
  • Track pillar changes as new earnings data arrives
  • Screen for similar mid-cap healthcare opportunities
Analyze HQY in Detail →

Pro Analysis

HQY — Score History

5055606570Apr 2Apr 12Apr 22May 2May 12May 22May 24v5
Score changes· 18 most recent
DateUQSQualityMoatGrowthRiskValueChange
May 22, 202656.462.846.055.058.762.9-2.4
May 7, 202658.859.946.071.858.761.3-0.1
May 3, 202658.959.946.071.858.761.60.0
Apr 26, 202658.959.946.071.858.761.5+0.2
Apr 19, 202658.759.946.071.858.760.3-0.3
Apr 18, 202659.059.946.071.858.762.5-2.5
Apr 16, 202661.560.246.071.858.778.20.0
Apr 15, 202661.560.646.071.858.778.2-0.1
Apr 14, 202661.660.846.071.858.778.2-0.2
Apr 12, 202661.861.246.071.858.778.7+0.4

HQY — Pillar Breakdown

Quality

62.8/100 (25%)

HealthEquity, Inc. shows solid profitability with healthy returns on capital and reasonable margins.

Capital Efficiency (ROIC)Weak

How effectively capital is deployed to generate returns.

Return on EquityModerate

Profitability relative to shareholders' equity.

Operating ProfitabilityStrong

Ability to convert revenue into operating profit.

Net ProfitabilityStrong

Bottom-line profit as a share of revenue.

Gross Profit / AssetsModerate

Asset productivity — how much gross profit each dollar of assets generates.

Cash GenerationStrong

Free cash flow relative to market value.

Growth

55.0/100 (20%)

HealthEquity, Inc. demonstrates healthy growth trends across revenue and earnings.

Recent Revenue TrendWeak

Revenue trajectory over the last twelve months.

3Y Revenue CAGRModerate

Compound annual revenue growth rate over 3 years.

EPS GrowthStrong

Year-over-year earnings per share growth.

Forward Revenue OutlookWeak

Analyst consensus for future revenue growth.

Forward EPS GrowthStrong

Analyst consensus for future earnings growth.

Risk

58.7/100 (15%)

HealthEquity, Inc. maintains a reasonable risk profile with manageable debt levels.

Financial LeverageWeak

Debt levels relative to earnings capacity.

Debt/EquityStrong

Total debt relative to shareholder equity.

Current RatioStrong

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageWeak

Earnings capacity relative to interest payments.

Valuation

62.9/100 (15%)

HealthEquity, Inc. trades at a reasonable valuation with decent earnings yield and FCF multiples.

Earnings YieldModerate

Inverse of forward P/E — higher yield means cheaper stock.

Price to Free Cash FlowStrong

How many years of FCF the market cap represents.

PEG RatioStrong

P/E relative to earnings growth — lower is more attractive.

EV/EBITDA vs SectorWeak

Enterprise value multiple relative to sector median.

Moat

46/100 (25%)

HealthEquity, Inc. possesses some competitive advantages but faces meaningful competition. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for HQY.

Score Composition

Quality
62.8×25%15.7
Growth
55.0×20%11.0
Risk
58.7×15%8.8
Valuation
62.9×15%9.4
Moat
46.0×25%11.5
Total
56.4Good

Financial Data

More Stock Analysis

How is the HQY UQS Score Calculated?

The UQS (Unified Quality Score) for HealthEquity, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses HealthEquity, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether HealthEquity, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.